전남대학교 중앙도서관

A pragmatic, open-label, randomized controlled trial of Plasma-Lyte-148 versus standard intravenous fluids in children receiving kidney transplants (PLUTO)

학술저널

issue: In Kidney International February 2024 105(2):364-375
Author: Hayes, Wesley N.
Laing, Emma
Brown, Rosemary
Silsby, Laura
Smith, Laura
Thomas, Helen
Kaloyirou, Fotini
Sharma, Rupa
Griffiths, James
Hume-Smith, Helen
Marks, Stephen D.
Kessaris, Nicos
Christian, Martin
Dudley, Jan
Shenoy, Mohan
Malina, Michal
Muorah, Mordi
Ware, Nicholas
Yadav, Pallavi
Reynolds, Ben
Bryant, William
Spiridou, Anastassia
Wray, Jo
Peters, Mark J.
DB Label: Database : ScienceDirect

원문보기: Full Text (ScienceDirect O/A) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

학술저널

issue: Trials. 21(1)
Author: McEniery, Carmel M.
Fisk, Marie^{Aff1, Aff2}
Miles, Karen
Kaloyirou, Fotini
Hubsch, Annette
Smith, Jane
Wilkinson, Ian B.^{Aff1, Aff2, Aff3}
Cheriyan, Joseph^{Aff1, Aff2, Aff3}
DB Label: Database : Springer Nature Journals

원문보기: Full Text (원문보기) Full Text (원문보기) OA (Springer) Open Access (BioMed Central) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial

학술저널

issue: Trials. 21(1)
Author: McEniery, Carmel M.
Fisk, Marie^{Aff1, Aff2}
Miles, Karen
Kaloyirou, Fotini
Hubsch, Annette
Smith, Jane
Wilkinson, Ian B.^{Aff1, Aff2, Aff3}
Cheriyan, Joseph^{Aff1, Aff2, Aff3}
DB Label: Database : Springer Nature Journals

원문보기: Full Text (원문보기) Full Text (원문보기) OA (Springer) Open Access (BioMed Central) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization

학술저널

issue: TRANSFUSION; JUN 2 2022, 8p.
Author: Harvala, Heli
Dung Nguyen
Simmonds, Peter
Lamikanra, Abigail A.
Tsang, Hoi Pat
Otter, Ashley
Maes, Piet
Webster, Mhairi
Clarkson, Adam
Kaloyirou, Fotini
Hopkins, Valerie
Laidlaw, Stephen M.
Carroll, Miles
Mora, Ana
Griffiths, Alexandra
MacLennan, Sheila
Estcourt, Lise
Roberts, David J.
DB Label: Database : Science Citation Index Expanded

원문보기: Full Text (Wiley-DB) 조회 - Impact Factor (JCR) 등재 - Web of Science 등재 - SCOPUS 원문복사신청 - RISS

Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENSITY-HIGH): protocol and study rationale for a randomised, open label, parallel group, mechanistic study

학술저널

issue: BMJ OPEN; 2021, 11 4, pe037457 7p.
Author: Cacciottolo, Paul J.
Kostapanos, Michalis S.
Sancho, Elena Hernan
Pavey, Holly
Kaloyirou, Fotini
Vamvaka, Evangelia
Helmy, Joanna
Hubsch, Annette
McEniery, Carmel M.
Wilkinson, Ian B.
Cheriyan, Joseph
DB Label: Database : Science Citation Index Expanded

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science 등재 - SCOPUS

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial

학술저널

issue: BMJ OPEN; SEP 2018, 8 9, pe022452 10p.
Author: Zhao, Tian Xiao
Kostapanos, Michalis
Griffiths, Charmaine
Arbon, Emma L.
Hubsch, Annette
Kaloyirou, Fotini
Helmy, Joanna
Hoole, Stephen P.
Rudd, James H. F.
Wood, Graham
Burling, Keith
Bond, Simon
Cheriyan, Joseph
Mallat, Ziad
DB Label: Database : Science Citation Index Expanded

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science 등재 - SCOPUS

THE EFFECTS OF ALIROCUMAB VERSUS EZETIMIBE ON TOP OF STATINS ON VASCULAR INFLAMMATION AND FUNCTION

학술저널

issue: In Journal of the American College of Cardiology 11 May 2021 77(18) Supplement 1:159-159
Author: Cacciottolo, Paul J.
Kostapanos, Michalis
Hubsch, Annette
Vamvaka, Evangelia
Kaloyirou, Fotini
Helmy, Joanna
Sancho, Elena H.
Pavey, Holly
Maki-Petaja, Kaisa
Wilkinson, Ian
Cheriyan, Joseph
DB Label: Database : ScienceDirect

원문보기: Full Text (ScienceDirect O/A) 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS 원문복사신청 - FRIC

학술저널

issue: BMJ Open; Sep2018, Vol. 8 Issue 9, p1-10, 10p
Author: Tian Xiao Zhao
Kostapanos, Michalis
Griffths, Charmaine
Arbon, Emma L.
Hubsch, Annette
Kaloyirou, Fotini
Helmy, Joanna
Hoole, Stephen P.
Rudd, James H. F.
Wood, Graham
Burling, Keith
Bond, Simon
Cheriyan, Joseph
Mallat, Ziad
DB Label: Database : Complementary Index

원문보기: 조회 - Impact Factor (JCR) 등재 - Web of Science (SCIE) 등재 - SCOPUS

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

학술저널

issue: NEJM evidence [NEJM Evid] 2022 Jan; Vol. 1 (1), pp. EVIDoa2100009. Date of Electronic Publication: 2021 Nov 22.
Author: Zhao TX; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Sriranjan RS; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Tuong ZK; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, United Kingdom.
Lu Y; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Sage AP; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Nus M; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Hubsch A; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Kaloyirou F; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Vamvaka E; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Helmy J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Kostapanos M; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Jalaludeen N; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Klatzmann D; Department of Inflammation, Immunopathology, and Biotherapy, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Tedgui A; Paris Cardiovascular Research Center, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France.
Rudd JHF; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Horton SJ; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Huntly BJP; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Hoole SP; Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Bond SP; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Clatworthy MR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cellular Genetics, Wellcome Sanger Institute, Hinxton, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Cheriyan J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
Mallat Z; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.; Paris Cardiovascular Research Center, Université de Paris, Institut National de la Santé et de la Recherche Médicale, Paris, France.
DB Label: Database : MEDLINE

원문보기

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택